INFO CENTER
« Cases and Current InvestigationsVitamin C
In re: Vitamin C Antitrust LitigationMaster File 1:06-MD-1738 (DGT)(JO), U.S.D.C., Eastern District of New York March 2009
Hausfeld LLP represents direct purchaser plaintiffs in the first antitrust case in the United States against Chinese manufacturers. The plaintiffs allege that Chinese pharmaceutical companies Hebei Welcome Pharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., JSPC America, Inc., Northeast Pharmaceutical (Group) Co. Ltd., Weisheng Pharmaceutical Co. Ltd., Shijiazhuang Pharmaceutical (USA), Inc., and China Pharmaceutical Group Ltd. conspired to fix prices and control export output of Vitamin C from December 1, 2001 to the present.
The suit represents China's growing economic clout in global markets and has raised important new issues concerning the assertion of a government’s role in the pricing and output decisions of the Chinese manufacturing defendants.
On November 6, 2008, the court denied Defendants’ motion to dismiss.
For more information, please contact the Hausfeld LLP attorneys working on the matter, Michael D. Hausfeld, Brian A. Ratner, Brent W. Landau or Melinda R. Coolidge.
Internet links:
Antitrust Suit Proceeds Against Chinese Vitamin C Makers http://www.law.com/jsp/article.jsp?id=1202425997056
Antitrust Case Against Chinese Manufacturers of Vitamin C Moves Forward http://www.law.com/jsp/tal/digestTAL.jsp?id=1196279893783
Practice Areas: Antitrust / Competition
Supporting Documents
» Third Amended Class Action Complaint
(PDF)
» Opinion re: Motion to Dismiss
(PDF)
